Evaluation of Anti-Diabetic Activity of Zinc Oxide Nanoparticles of Gymnema sylvestre Extract on Wistar Rats
Abstract
Diabetes mellitus is described as a metabolic disorder, which was characterised by high blood glucose levels, which were resulted due to insufficient insulin secretion. There were major complications related to diabetes mellitus. To evaluate the antidiabetic effect of Gymnema sylvestre Zinc Oxide Nanoparticles. Streptozotocin (STZ) of 50mg/kg is used for the induction of diabetes into Wistar rats. The animals were divided into 6 groups. Group-I represented as Control; Group-II represented as diabetic control (STZ ); Group-III represented as 5 mg/kg body weight of glibenclamide + diabetes; Group-IV represented as Gymnema sylvestre extract + diabetes; Group-V represented as 100 µg Gymnema sylvestre Zinc Oxide nanoparticles + diabetes; group-6- Gymnema sylvestre Zinc Oxide Nanoparticles 200 µg + diabetes. The GsZnONPs were inspected to morphological properties using UV spectrophotometer and FTIR. The GsZnONPs shown characterization peak at 300nm. The study has shown that GsZnONPs treated group has shown reduced glucose concentration. The histo-pathological alterations were also studied in all experimental groups. The pathology results of GsZnONPs (200 µg) group has shown the regeneration of islets cells of pancreas. The research study has proved that Gymnema sylvestre ZnO NPs exerts antidiabetic properties.
Keywords: Diabetes, Gymnema sylvestre, Zinc Oxide nanoparticles
Keywords:
Gymnema sylvestre, Zinc Oxide nanoparticles, DiabetesDOI
https://doi.org/10.22270/jddt.v13i11.6283References
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care. 2004 May 1;27(5):1047-53. https://doi.org/10.2337/diacare.27.5.1047 PMid:15111519
Lebovitz HE. Diagnosis, classification, and pathogenesis of diabetes mellitus. J Clin Psychiatry. 2001;62:5-9,40-1.
Sami W, Ansari T, Butt NS, Hamid MRA. Effect of diet on type 2 diabetes mellitus: A review. Int J Health Sci (Qassim). 2017; 11(2):65-71.
Rajaei E, Jalali MT, Shahrabi S, Asnafi AA, Pezeshki SMS. HLAs in Autoimmune Diseases: Dependable Diagnostic Biomarkers? Curr Rheumatol Rev. 2019;15(4):269-276.
Kühl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care. 1998 Aug;21 Suppl 2:B19-26. https://doi.org/10.2174/1573397115666190115143226 PMid:30644346
Unger RH, Orci L. Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16009-12. . https://doi.org/10.1073/pnas.1006639107 PMid:20798346 PMCid:PMC2941311
Ramachandran, A. (2014). Know the signs and symptoms of diabetes. The Indian journal of medical research, 140(5), 579.
Kotaru M, Korimelli S. Evaluation of Anti-Diabetic Activity of Silver Nanoparticles Synthesized from Ethanolic Extract of Phyllanthus niruri on Wistar Rats. Journal of Drug Delivery and Therapeutics. 2023 Jun 15;13(6):83-8. https://doi.org/10.22270/jddt.v13i6.6098
Arthur B. and Chausmer S. (1998) Zinc, insulin and diabetes. J. Am. Coll. Nutr. 17, 109-115 https://doi.org/10.1080/07315724.1998.10718735 PMid:9550453
Wells I.C. (2008) Evidence that the etiology of the syndrome containing type 2 diabetes mellitus results from abnormal magnesium metabolism. Canadian J. Physiol. Pharmacol. 86, 16-24 10.1139/Y07-122 . https://doi.org/10.1139/Y07-122 PMid:18418443
Wang Z.Q. and Cefalu W.T. (2010) Current concepts about chromium supplementation in type 2 diabetes and insulin resistance. Curr. Diabetes Rep. 10, 145-151 https://doi.org/10.1007/s11892-010-0097-3 PMid:20425574
Haase H., Overbeck S. and Rink L. (2008) Zinc supplementation for the treatment or prevention of disease: current status and future perspectives. Exp. Gerontol. 43, 394-408 10.1016/j.exger.2007.12.002 . https://doi.org/10.1016/j.exger.2007.12.002 PMid:18221847
Edmin S., Dodson G. and Cutfield S. (1980) Role of zinc in insulin biosynthesis: some possible zinc insulin interactions in the pancreatic beta cells. Diabetologia 19, 174-182 https://doi.org/10.1007/BF00275265 PMid:6997118
Smidt K., Jessen N., Petersen A.B. et al.. (2009) SLC30A3 responds to glucose-and zinc variations in ß-cells and Is critical for insulin production and in vivo glucose-metabolism during ß-cell stress. PLoS ONE 4, e5684 https://doi.org/10.1371/journal.pone.0005684 PMid:19492079 PMCid:PMC2683566
Rungby J. (2010) Zinc, zinc transporters and diabetes. Diabetologia 53, 1549-1551 10.1007/s00125-010-1793-x . https://doi.org/10.1007/s00125-010-1793-x PMid:20490449
Elshama SS, Abdallah ME, Abdel-Karim RI. Zinc oxide nanoparticles: therapeutic benefits and toxicological hazards. The Open Nanomedicine Journal. 2018 Jul 19;5(1). https://doi.org/10.2174/1875933501805010016
Kanetkar P, Singhal R, Kamat M. Gymnema sylvestre: a memoir. Journal of clinical biochemistry and nutrition. 2007;41(2):77-81. https://doi.org/10.3164/jcbn.2007010 PMid:18193099 PMCid:PMC2170951
Kameswaran S, Perumal K. Extraction and Purification of Gymnemic Acid from Gymnema sylvestre R. Br. Medicinal Plants: Biodiversity, Sustainable Utilization and Conservation. 2020:521-9. https://doi.org/10.1007/978-981-15-1636-8_29
Murali Santhoshkumar, Agilan Balupillai, Ernest David et al. Biological Fabrication and Characterization of Zinc Oxide Nanoparticles Using Gymnema sylvestre Potentially Produces Toxicity in Breast Cancer Cells -MCF-7, 03 February 2021, PREPRINT (Version 1) https://doi.org/10.21203/rs.3.rs-161267/v1
Hasnidawani JN, Azlina HN, Norita H, Bonnia NN, Ratim S, Ali ES. Synthesis of ZnO nanostructures using sol-gel method. Procedia Chemistry. 2016 Jan 1;19:211-6. https://doi.org/10.1016/j.proche.2016.03.095
Singh DK, Pandey DK, Yadav RR, Singh D. A study of nanosized zinc oxide and its nanofluid. Pramana. 2012 May;78:759-66. https://doi.org/10.1007/s12043-012-0275-8
Al-Quraishy S, Dkhil MA, Moneim AE. Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats. International journal of nanomedicine. 2015; 10:6741. https://doi.org/10.2147/IJN.S91377 PMid:26604749 PMCid:PMC4631434
Vianna R, Brault A, Martineau LC, Couture R, Arnason JT, Haddad PS. In vivo anti-diabetic activity of the ethanolic crude extract of Sorbus decora CK Schneid.(Rosacea): a medicinal plant used by Canadian James Bay Cree nations to treat symptoms related to diabetes. Evidence-Based Complementary and Alternative Medicine. 2011 Jan 1;2011. https://doi.org/10.1093/ecam/nep158 PMid:19887507 PMCid:PMC3163474
Kifle ZD, Enyew EF. Evaluation of in vivo antidiabetic, in vitro αamylase inhibitory, and in vitro antioxidant activity of leaves crude extract and solvent fractions of Bersama abyssinica fresen (melianthaceae). Journal of Evidence-Based Integrative Medicine. 2020; 25:2515690X20935827 https://doi.org/10.1177/2515690X20935827 PMid:32718177 PMCid:PMC7388106
Published



How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).